Rallybio Corporation share price logo

Rallybio Corporation

NASDAQ: RLYB

Small Cap

$15.81

-0.12

(-0.75%)

as on

Rallybio Corporation Stock Performance

as on June 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $15.63
    $15.91
    downward going graph

    1.14%

    Downside

    0.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.40
    $17.57
    downward going graph

    84.82%

    Downside

    11.16%

    Upside

    downward going graph

Rallybio Corporation share price movements today

Previous Close
$15.93
Open
$15.80
Volume
540.9K
Day's Low - High
$15.63 - $15.91
52 Week Low - High
$2.40 - $17.57

Rallybio Corporation Historical Returns

1 Month Return
+ 0.31 %
3 Month Return
+ 74.86 %
1 Year Return
+ 538.43 %
3 Year Return
-75.54 %
5 Year Return
0 %

Rallybio Corporation Stock Fundamentals & Key Indicators

Check Rallybio Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$92.6M

EPS (TTM)

-5.52

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-30.4M

Revenue (TTM)

858.0K

Profit Margin

0.00%

Return On Equity TTM

-14.98%

Rallybio Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rallybio Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$92.6MNANA0.00%NA
BUY$37.1B64.01%69.8712.55%NA
BUY$114.6B148.93%26.835.51%NA
BUY$63.9B15.61%14.8829.65%0.59%

Stock Returns calculator for Rallybio Corporation Stock including INR - Dollar returns

The Rallybio Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Rallybio Corporation investment value today

Current value as on today

₹6,91,966

Returns

₹5,91,966

(+591.97%)

Returns from Rallybio Corporation Stock

₹5,32,400 (+532.4%)

Dollar Impact

₹59,566 (+59.57%)

Analyst Recommendation on Rallybio Corporation Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Rallybio Corporation. Average target price of $8

Rallybio Corporation Share Price Target

Get share price movements and forecasts by analysts on Rallybio Corporation.

What analysts predicted

-97.63%DOWNSIDE

Target Price

$8

Current Price

$15.81

Analyzed by

12 Analysts

Target

$8.00

Rallybio Corporation target price $8, a slight downside of -97.63% compared to current price of $15.81. According to 12 analysts rating.

Indian Investors' Interest in Rallybio Corporation Stock

Search interest for Rallybio Corporation Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-88% versus previous 30 day period

Rallybio Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-21
-19
-17
-12
-11
-9
-10
-6
-6
-4
EBITDA
-21
-19
-17
-12
-11
-9
-10
-6
-6
-4
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-20
-19
-16
-11
-11
-9
-9
16
-5
-8
Income Tax Expense
0
0
0
-
0
-
0
-
-
-
Net Income
-20
-19
-16
-11
-11
-9
-9
16
-5
-8
Net Profit Margin
-8878.07%
0.00%
-5430.10%
-3834.78%
-29063.16%
-4452.36%
-4576.89%
7554.72%
-2636.04%
-3904.72%

Rallybio Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
0
Gross Profit
0
0
0
0
0
0
0
Operating Income
-17
-25
-45
-67
-78
-60
-28
EBITDA
-17
-25
-45
-67
-78
-60
-27
Interest Expense
0
0
0
2
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-17
-26
-47
-67
-74
-57
-8
Income Tax Expense
0
0
1
-1
-2
-2
-
Net Income
-17
-26
-47
-66
-74
-57
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-9084.12%
-1046.39%

Rallybio Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-19
-16
-11
-11
-9
-9
16
-5
-8
Operating Cash Flow
-15
-10
-13
-9
-10
-8
-6
-4
-7
Investing Cash Flow
10
2
22
-1
11
3
29
3
17
Financing Cash Flow
-
5
0
0
-
0
-
0
0
Change in Cash
-5
-2
8
-11
0
-5
22
0
9

Rallybio Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-47
-66
-74
-57
-8
Operating Cash Flow
-22
-45
-57
-60
-49
-29
Investing Cash Flow
-2
-2
-112
27
33
47
Financing Cash Flow
144
82
51
0
5
0
Change in Cash
120
35
-118
-32
-10
17

Global Institutional Holdings in Rallybio Corporation

Funds
Holdings
New Leaf Venture Partners, L.L.C.
62.42%
AJU IB Investment Co Ltd
1.63%
Mariner Wealth Advisors LLC
0.87%
Acadian Asset Management LLC
1.71%
Canaan Partners XI LLC
8.51%

Insights on Rallybio Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RLYB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RLYB stock has moved up by 74.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Rallybio Corporation Common Stock has experienced a drawdown of -75.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 54.1%

About Rallybio Corporation

Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.
OrganisationRallybio Corporation
Headquarters234 Church Street, New Haven, CT, United States, 06510
IndustryBiotechnology
CEODr. Stephen Uden M.D., MBBS
E-voting on sharesClick here to vote

Key Management of Rallybio Corporation

Name

Title

Dr. Martin W. MacKay Ph.D.

Co-Founder & Chairman

Dr. Stephen Uden M.D., MBBS

Co-Founder, President, CEO & Director

Mr. Jonathan I. Lieber M.B.A.

CFO & Treasurer

FAQs

What is Rallybio Corporation share price today?

Rallybio Corporation share price today is $15.81 as on at the close of the market. Rallybio Corporation share today touched a day high of $15.91 and a low of $15.63.

What is the 52 week high and 52 week low for Rallybio Corporation share?

Rallybio Corporation share touched a 52 week high of $17.57 on and a 52 week low of $2.4 on . Rallybio Corporation stock price today i.e. is closed at $15.81,which is 10.04% down from its 52 week high and 558.75% up from its 52 week low.

What is Rallybio Corporation's market capitalisation today?

Rallybio Corporation market capitalisation is $0.00T as on .

How to invest in Rallybio Corporation Stock (RLYB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rallybio Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rallybio Corporation Shares that will get you 0.0949 shares as per Rallybio Corporation share price of $15.81 per share as on June 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Rallybio Corporation Stock (RLYB) from India?

Indian investors can start investing in Rallybio Corporation (RLYB) shares with as little as ₹94.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.35 in Rallybio Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Rallybio Corporation share’s latest price of $15.81 as on June 24, 2026 at 1:29 am IST, you will get 0.6325 shares of Rallybio Corporation. Learn more about fractional shares .